Concomitant VWD and Hemophilia
1 clinical trials · Condition
◉ Watch Concomitant VWD and Hemophilia
| Record | Firm | Date |
|---|---|---|
| Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A (NCT05500807) | Bleeding and Clotting Disorders Institute Peoria, Illinois | 2022-11-01 |
Track Concomitant VWD and Hemophilia automatically
Every clearance here is in the API, with alerts when new ones post.